Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.875 GBX | 0.00% | +0.88% | +15.00% |
Apr. 03 | Allergy Therapeutics Announces Resignation of Mary Tavener as Non-Executive Director | CI |
Mar. 27 | EARNINGS AND TRADING: Solid State ups outlook; Quartix trading in line | AN |
Sales 2022 | 72.77M 91.33M | Sales 2023 | 59.59M 74.78M | Capitalization | 7.13M 8.95M |
---|---|---|---|---|---|
Net income 2022 | -13M -16.32M | Net income 2023 | -43M -53.97M | EV / Sales 2022 | 1.7 x |
Net cash position 2022 | 9.99M 12.53M | Net Debt 2023 | 21.14M 26.54M | EV / Sales 2023 | 0.47 x |
P/E ratio 2022 |
-9.69
x | P/E ratio 2023 |
-0.16
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 6.79% |
1 week | +0.88% | ||
Current month | -0.86% | ||
1 month | +0.88% | ||
3 months | +19.79% | ||
6 months | +98.28% | ||
Current year | +15.00% |
Managers | Title | Age | Since |
---|---|---|---|
Manuel Llobet
CEO | Chief Executive Officer | 60 | 09-06-30 |
Shaun Furlong
DFI | Director of Finance/CFO | - | 22-03-31 |
Murray Skinner
CTO | Chief Tech/Sci/R&D Officer | - | 03-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 17-06-05 | |
Peter Jensen
CHM | Chairman | 73 | 10-09-30 |
Anthony Parker
BRD | Director/Board Member | - | 22-12-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 2.875 | 0.00% | 320,409 |
24-05-02 | 2.875 | 0.00% | 973,172 |
24-05-01 | 2.875 | -0.86% | 759,943 |
24-04-30 | 2.9 | 0.00% | 782,547 |
24-04-29 | 2.9 | +1.75% | 1,571,923 |
Delayed Quote London S.E., May 03, 2024 at 11:35 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+15.00% | 172M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |
- Stock Market
- Equities
- AGY Stock